Vaso Occlusive Crisis Market Size

  • Report ID: 5333
  • Published Date: Oct 19, 2023
  • Report Format: PDF, PPT

Vaso Occlusive Crisis Market Size

Vaso Occlusive Crisis Market size is anticipated to reach USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of vaso occlusive crisis was over USD 10 billion. Some medical devices, such as portable oxygen concentrators and home monitoring equipment, can help individuals with SCD manage their condition more effectively. Early diagnosis and monitoring of SCD and VOCs are crucial. Diagnostic tools include hemoglobin electrophoresis, genetic testing, and various blood tests to assess the disease's severity and identify potential triggers for vaso-occlusive crises. The Vaso-Occlusive Crisis market is an evolving field with ongoing research and development. The introduction of new therapies and advances in understanding the disease can significantly impact the market. Additionally, there is a growing focus on improving the overall quality of life for individuals with SCD by providing comprehensive care and support. This market is driven by both medical and technological advancements, as well as the increasing awareness of the challenges faced by those with sickle cell disease.

A vaso-occlusive crisis (VOC) is a common and painful complication of sickle cell disease (SCD). It occurs when sickle-shaped red blood cells block small blood vessels, leading to pain and tissue damage. SCD is a genetic blood disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen throughout the body. When the hemoglobin becomes deoxygenated, it can cause red blood cells to change shape, becoming rigid and forming a characteristic sickle shape. The VOC market primarily encompasses healthcare products and services related to the diagnosis, treatment, and management of vaso-occlusive crises in individuals with sickle cell disease. This market is significant because SCD affects millions of people worldwide, particularly those of African, Mediterranean, Middle Eastern, and Indian descent


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5333
  • Published Date: Oct 19, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for the pharmaceutical sector is the major factor driving the market growth.

The market size of vaso occlusive crisis is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Novartis Pharmaceuticals Corporation, Bristol-Myers Squibb, Pfizer Inc., Global Blood Therapeutics, AstraZeneca, Sanofi, and others.

The outpatient care segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample